Skip to content
Recall Observatory FDA recall evidence

Device product

PHADIA Varelisa Cardiolipin IgM Cardiolipin autoantibody immunological test system (IgM class antibodies)

Z-2285-2012

August 02, 2012

Class III

Product summary

Firm
Phadia US Inc
Event
Event 62572
Status
Terminated
Classification
Class III
Quantity
837 kits (96 assays per kit), total of 80,352 individual assays
Official record key
device-enforcement:Z-2285-2012

Official wording

Reason: Customers were not following the labeled assay procedure. This was due to a letter issued to them in 2004 from Phadia GmbH, which indicated that customers could omit the pre-wash step. The omission of the pre-wash step, when combined with a change in material source in kit lot #0067, caused elevated results.

Code information: Article Number 15696 Lot number #0067

Distribution pattern: USA Nationwide.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Customers were not following the labeled assay procedure. This was due to a letter issued to them in 2004 from Phadia GmbH, which indicated that customers could omit the pre-wash step. The omission of the pre-wash step, when combined with a change in material source in kit lot #0067, caused elevated results.